Europe High Throughput Screening Market Size & Outlook
The high throughput screening market in Europe is expected to reach a projected revenue of US$ 10,438.4 million by 2033. A compound annual growth rate of 8.9% is expected of Europe high throughput screening market from 2026 to 2033.
- Clinical Diagnostics
- Genetic Testing
- High Throughput Screening Market Outlook
- Genetic Testing
Revenue, 2025 (US$M)
$5,296.1
Estimate, 2026 (US$M)
$5,739.0
Forecast, 2033 (US$M)
$10,438.4
CAGR, 2026 - 2033
8.9%
Global Market
Related Markets
Ask Prism AI anything about the high throughput screening market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
Europe high throughput screening market highlights
- The Europe high throughput screening market generated a revenue of USD 5,296.1 million in 2025.
- The market is expected to grow at a CAGR of 8.9% from 2026 to 2033.
- In terms of segment, drug discovery programs was the largest revenue generating application in 2025.
- Cell- & organ-based screening is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 5,296.1 million |
| Market revenue in 2033 | USD 10,438.4 million |
| Growth rate | 8.9% (CAGR from 2026 to 2033) |
| Largest segment | Drug discovery programs |
| Fastest growing segment | Cell- & organ-based screening |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug discovery programs, Chemical biology programs, Biochemical screening, Cell- & organ-based screening |
| Key market players worldwide | Agilent Technologies Inc, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer, Bio-Rad Laboratories Inc, Aurora Biomed, Tecan Group AG, Promega Corporation, Charles River Laboratories International Inc, Creative-Biolabs |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.6% of the global high throughput screening market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,873.5 million by 2033.
No credit card required*
Publish Date: Apr 01, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
High Throughput Screening Market Scope
High Throughput Screening Market segmentation & scope
High Throughput Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Tecan Group AG | View profile | 3,591 | Seestrasse 103, Mannedorf, Switzerland, 8708 | www.tecan.com |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | www.creative-biolabs.com |
| Promega Corporation | View profile | - | - | - |
| Aurora Biomed | View profile | 11-50 | Vancouver, British Columbia, Canada, North America | www.aurorabiomed.com |
Europe High Throughput Screening Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to High Throughput Screening Market Outlook will help companies and investors design strategic landscapes.
Drug Discovery Programs was the largest segment with a revenue share of 62.06% in 2025.
Horizon Databook has segmented the Europe high throughput screening market based on drug discovery programs, chemical biology programs, biochemical screening, cell- & organ-based screening covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe High Throughput Screening Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug discovery programs
- Chemical biology programs
- Biochemical screening
- Cell- & organ-based screening
- Europe High Throughput Screening Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Cell Based Assays
- 3D - Cell Cultures
- Ultra High Throughput Screening
Reasons to subscribe to High Throughput Screening Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of High Throughput Screening Market Outlook databook
- Our clientele includes a mix of High Throughput Screening Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe High Throughput Screening Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe High Throughput Screening Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe High Throughput Screening Market, 2021-2033 (US$M)
Europe Application - High Throughput Screening Market Statistics, 2025 - 2033 (US$M)
